Dermatol. praxi. 2024;18(4):202-205 | DOI: 10.36290/der.2024.040
Dupilumab and prurigo nodularis in hepatopathy
- I. dermatovenerologická klinika FN u sv. Anny v Brně, Lékařská fakulta Masarykovy univerzity v Brně
The case report describes a 67-year-old female patient with long-lasting severe prurigo nodularis, which arose in association with hepatopathy. Due to this comorbidity, the options for systemic therapy were limited. Dupilumab proved to be an effective and safe treatment in this patient. The effect of dupilumab on liver metabolism and regeneration has not yet been fully investigated. In practice, however, there are no recorded cases of liver function deterioration or even liver failure following this drug.
Keywords: prurigo nodularis, hepatopathy, biological treatment, dupilumab.
Accepted: November 6, 2024; Published: November 22, 2024 Show citation
PDF will be unlocked 22.11.2025 |
References
- Marani M, Madan V, Le TK, et al. Dysregulation of the Skin-Liver Axis in Prurigo Nodularis: An Integrated Genomic, Transcriptomic, and Population-Based Analysis. Genes (Basel). 2024;15(2):146.
Go to original source... 
Go to PubMed... - Paganini C, Talamonti M, Maffei V, et al. Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks. J Clin Med. 2024;13(3):878. Go to original source... Go to PubMed...
- Goh YP, Henderson NC, Heredia JE, et al. Eosinophils secrete IL-4 to facilitate liver regeneration. Proc Natl Acad Sci U S A. 2013;110(24):9914-9. Go to original source... Go to PubMed...
- Weng SY, Wang X, Vijayan S, et al. IL-4 Receptor Alpha Signaling through Macrophages Differentially Regulates Liver Fibrosis Progression and Reversal. EBioMedicine. 2018;29:92-103. Go to original source... Go to PubMed...
- Ly K, Smith MP, Thibodeaux Q, et al. Dupilumab in patients with chronic hepatitis B on concomitant entecavir. JAAD Case Rep. 2019;5(7):624-626. Go to original source... Go to PubMed...
- Mota F. Atopic Dermatitis Patient With Hepatitis C Treated With Dupilumab-A Case Report. Actas Dermosifiliogr. 2024;115(4):T420-T421. Go to original source... Go to PubMed...
- Drucker AM, Lam M, Flohr C, et al. Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey. Dermatitis. 2022;33(3):200-206. Go to original source... Go to PubMed...
- Dupixent in AD, European Public Assessment Report. Sanofi-aventis groupe; July 2017, accessed via, last access on 13. 05. 2022. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Public_assessment_report/human/004390/WC500236509.pdf.
- Čapková Š. Těžká forma atopické dermatitidy u chlapce po transplantaci jater a dvou následných retransplantacích. Dermatol. praxi. 2022;16(3):153-156. Go to original source...